Aarti Drugs Limited maintains a consistent history of rewarding its public shareholders through regular interim and final dividend distributions. The company balances capital returns with the need to retain earnings for ongoing research, plant modernizations, and capital expenditure projects, reflecting a disciplined approach to capital allocation.